Del 43 - Advances in Clinical Chemistry

Advances in Clinical Chemistry

Inbunden, Engelska, 2007

2 499 kr

Beställningsvara. Skickas inom 7-10 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

Volume 43 of the Advances in Clinical Chemistry series contains review articles of wide interest to clinical laboratory scientists and diagnostic adventurers. In this volume, the biochemistry of bilirubin, the end-product of heme metabolism, is explored with respect to its potential beneficial role in preventing oxidative changes associated with a variety of pathological conditions, including atherosclerosis, cancer, and inflammatory, autoimmune and other degenerative diseases.

Produktinformation

Utgivningsdatum2007-02-06
Mått152 x 229 x undefined mm
Vikt520 g
FormatInbunden
SpråkEngelska
SerieAdvances in Clinical Chemistry
Antal sidor304
FörlagElsevier Science
ISBN9780123737038

Tillhör följande kategorier

Medicin: allmänt inom Medicin

Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.

The Heme Catabolic Pathway and its Protective Effects on Oxidative Stress-Mediated DiseasesCyclooxygenase-2 and Tumor BiologyOligonucleotide Probes for RNA-Targeted Fluorescence In Situ HybridizationActivin A In Brain InjuryMethods for Predicting Human Drug MetabolismA Summary Analysis of Down Syndrome Markers in the Late First TrimesterEstrogen Hydroxylation in OsteoporosisCytochrome P450: Another Player in the Myocardial Infarction Game?Index